Skip to main content

Author: Doug Campbell

VUMC-led study finds Moderna COVID vaccine safe and effective for children

May. 12, 2022—  by Bill Snyder Moderna’s COVID-19 vaccine is safe and generates robust immune responses in children ages 6 to 11 years, a national clinical trial co-led by Vanderbilt University Medical Center vaccine expert C. Buddy Creech, MD, MPH, has found. The two-dose vaccine (given approximately one month apart) led to antibody responses in more than...

Read more


Vanderbilt University Hospital and Vanderbilt Tullahoma-Harton Hospital receive top safety grade from Leapfrog Group

May. 11, 2022—Both Vanderbilt University Hospital (VUH) and Vanderbilt Tullahoma-Harton Hospital have been recognized as being among the safest hospitals in the nation after receiving a spring 2022 safety grade of “A” from the Leapfrog group.

Read more


VUMC again named a Leader in LGBTQ+ Healthcare Equality

Mar. 28, 2022—Vanderbilt University Medical Center has been named a Leader in LGBTQ+ Healthcare Equality by the Human Rights Campaign Healthcare Equality Index (HEI).

Read more


Match Day reveals next stop on students’ medical journeys

Mar. 21, 2022—by Kathy Whitney Vanderbilt’s Match Day celebration was held in person this year and allowed for family and friends to gather in Langford Auditorium to support the fourth-year medical students as they learned which residency programs they matched into. Held on March 18, Match Day was the crowning moment of the National Resident Match Program,...

Read more


VUMC recognized for antimicrobial drug stewardship efforts

Feb. 17, 2022—by Paul Govern The Infectious Diseases Society of America (IDSA) has designated Vanderbilt University Medical Center an Antimicrobial Stewardship Center of Excellence. Antimicrobial stewardship is the effort to measure and improve how antibiotics and other antimicrobial drugs are prescribed by clinicians and used by patients. Bacteria, viruses, fungi and other pathogens can become resistant to...

Read more



Children’s Hospital patients get creative for Vanderbilt Men’s Basketball team as part of Coaches vs. Cancer

Feb. 3, 2022—by Christina Echegaray Ariana Robinson, 14, loves family and animals, appreciates the vibrancy of life and believes in hard work. Logan Hall, 13, is an avid sports fan and athlete and is passionate about a good motivational speech from his coaches before a football or baseball game. Both Ariana and Logan have acute myeloid leukemia...

Read more


VUMC to support $170 million NIH nutrition research initiative

Jan. 20, 2022—  by Paul Govern The National Institutes of Health (NIH) has announced it will award $170 million over five years to clinics and centers across the country to study individual responses to food and dietary routines and develop electronic algorithms to support personalized nutrition recommendations. The program, called Nutrition for Precision Health (NPH), will recruit...

Read more


Grant boosts vaccine effectiveness research

Jan. 6, 2022—by Nancy Humphrey Investigators at Vanderbilt University Medical Center have received a $10.7 million research award from the Centers for Disease Control and Prevention (CDC) to continue the IVY Research Network, originally created in 2019 to look at how well flu vaccines work at preventing severe flu illness, and expanded in 2021 to enroll patients...

Read more


Opioid use disorder treatment access increases in areas with large Medicaid population

Jan. 4, 2022—  by Jill Clendening Researchers report that in communities where Medicaid is a more common source of insurance, providers of buprenorphine, an effective treatment for opioid use disorder (OUD), are much less likely to discriminate between Medicaid and privately insured prospective patients, but patients with either type of coverage still face many barriers to obtaining...

Read more


Study finds apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention, reduced bleeding complications

Dec. 21, 2021—  by Jill Clendening There is strong evidence that the medication apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention in patients with atrial fibrillation (AF), with both reduced rates of severe bleeding complications as well as strokes, according to study published Dec. 21 in JAMA. An estimated 3 million to 6 million persons...

Read more


Year in Review 2021: A year of perseverance, achievement at VUMC

Dec. 16, 2021—The fight against COVID-19 carried on, but while the pandemic dominated the news in 2021, there were many other achievements that made headlines this year at Vanderbilt University Medical Center.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more